Skip to Main Content

Yale Medical Oncology-Hematology Program

The Yale Medical Oncology-Hematology Fellowship Program is a 36-month training program that provides comprehensive clinical training in neoplasia and classical hematology and a robust research experience to prepare fellows for lifelong careers in academic medicine.

Why Choose Yale?

Our fellowship program offers unparalleled, personalized attention to each of our fellows, with exceptionally strong mentorship for individualized career development.

Our fellows receive robust clinical training in all areas of medical oncology, malignant hematology, and classical hematology and have unlimited access to an incomparable breadth of research opportunities in clinical and translational medicine and basic science, throughout Smilow Cancer Hospital, Yale Cancer Center, Yale School of Medicine, and Yale University.

Our institution provides numerous opportunities for advanced training, including a prestigious Master of Health Science program, an Investigative Medicine PhD program, and a T32 training grant for interested fellows to further their scholarly pursuits beyond fellowship.

Bolstered by a supportive, collaborative culture, the vast majority of graduates from our fellowship program attain positions in academic medicine.


The goal of our fellowship program is to train the next generation of academic investigators and clinicians, who are at the leading edge of innovation in medical oncology and hematology.


Most fellows in our program complete 18 months of clinical training and have at least 18 months dedicated to research endeavors. Clinical training is divided evenly among medical oncology, malignant hematology, and classical hematology, with inpatient and ambulatory experiences, numerous educational conferences and tumor boards, and rich exposure to a diverse patient population at Yale Cancer Center, Smilow Cancer Hospital, and the West Haven VA Hospital. A small number of fellows may elect to train only in medical oncology or hematology.

Upon starting fellowship, each fellow is assigned a mentorship committee, consisting of core faculty who are committed to training and helping our fellows navigate their individual career trajectories.

During their research years, fellows have unlimited access to clinical and basic science investigators throughout Yale Cancer Center and the Yale campus.

Advanced training

A number of opportunities for advanced training are available for interested fellows, including:

Program Leadership and Administration

Our fellowship program leadership is entirely devoted to the professional development of every one of our fellows. The members of the leadership team are:

  • Program Director: Alfred Ian Lee, MD, PhD
  • Associate Program Director, Medical Oncology: Sarah B. Goldberg, MD, MPH
  • Associate Program Director, Hematology: Nikolai A. Podoltsev, MD, PhD
  • Associate Program Director, Research: Michael D. Hurwitz, MD, PhD
  • Program Administrator and Coordinator: Lucilina Gilkes

Fellowship Application

The program accepts ten trainees per year. All applications for the 2022 Training Program in Hematology/Medical Oncology will be electronically processed through the ERAS (Electronic Residency Application Service) website. Interviews are granted by invitation in September and October. Selection for the program is made through the NRMP (National Resident Matching Program). The Sections of Medical Oncology and Hematology actively support Yale University policies and programs for affirmative action. The Fellowship Program is fully committed to recruitment and development of minority group members and women.

Submission to the Hematology/Medical Oncology fellowship through ERAS begins in July with an application deadline for the end of August. Questions regarding the application process can be directed to Lucilina Gilkes (

Additional information about Graduate Medical Education programs at Yale, as well as information about Yale New Haven Hospital, Yale University, and New Haven, is available here.